BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10562482)

  • 1. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
    Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
    Amjad S; Sami SA; Basir MN; Hameed K; Fujita M; Ahmad HR
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):160-5. PubMed ID: 24532613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third heart sound revisited: a correlation with N-terminal pro brain natriuretic peptide and echocardiography to detect left ventricular dysfunction.
    Narain VS; Puri A; Gilhotra HS; Sadiq PA; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(1):31-4. PubMed ID: 15852891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
    Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma concentrations of N-terminal pro-brain natriuretic peptide reflect the presence of mildly reduced left ventricular diastolic function in hypertension.
    Furumoto T; Fujii S; Mikami T; Inoue M; Nishihara K; Kaga S; Imagawa S; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Sobel BE
    Coron Artery Dis; 2006 Feb; 17(1):45-50. PubMed ID: 16374141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
    Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.
    Talwar S; Siebenhofer A; Williams B; Ng L
    Heart; 2000 Mar; 83(3):278-82. PubMed ID: 10677405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
    Bhalla V; Isakson S; Bhalla MA; Lin JP; Clopton P; Gardetto N; Maisel AS
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):73S-81S. PubMed ID: 15752936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
    Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
    Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction.
    Hughes D; Talwar S; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 1999 Apr; 96(4):373-80. PubMed ID: 10087244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Thanapiboonpol P; Nakyen S; Udompunturak S
    J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.
    Limkakeng AT; Drake W; Mani G; Freeman D; Best R; Newby LK; Chandra A
    Am J Emerg Med; 2012 Jan; 30(1):214-7. PubMed ID: 21185671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Am J Cardiol; 2005 Mar; 95(5):553-7. PubMed ID: 15721090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.
    Groenning BA; Raymond I; Hildebrandt PR; Nilsson JC; Baumann M; Pedersen F
    Heart; 2004 Mar; 90(3):297-303. PubMed ID: 14966052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.